2m 2m 2m 2m 2m 2m 2m
Anebulo Pharma (ANEB)
OTC
$0.38+$0.05 (+13.56%)
Price as of Feb 27, 2026 7:57 PM EST- $13.6MMarket Cap
- -79.11%1-Year Change
- BiotechnologyIndustry
Anebulo Pharma (ANEB)
$0.38+$0.05 (+13.56%)
ANEB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.34 | ||
Change | $0.00 (0.00%) | ||
Open | $0.34 | ||
High | $0.34 | ||
Low | $0.34 | ||
Previous Close | $0.34 | ||
Volume | 100 | ||
30-Day Average Volume | 851 | ||
1-Week Change | -8.59% | ||
1-Month Change | -29.14% | ||
1-Year Change | -79.11% | ||
3-Year Change | -85.87% | ||
5-Year Change | -95.61% | ||
Fundamentals | |||
Shares Outstanding | 40.8M | ||
Total Assets | $9.4M | ||
Market Cap | $13.6M | ||
Enterprise Value | $4.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.3M | ||
EBIT | $17,000.00 | ||
EBITDA | $17,000.00 | ||
Net Working Capital | $7.8M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 269 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -7 | ||
PEG | N/A | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||